Panacea Biotec and Russia’s sovereign wealth fund, Russian Direct Investment Fund (RDIF) announced the start of production of the Sputnik V vaccine, with commercial manufacture kick-starting in summer. Under a tie-up, RDIF and Panacea have agreed to produce 100 million doses per year of the vaccine.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3bQj4MW
No comments:
Post a Comment